196 related articles for article (PubMed ID: 4566479)
21. Role of activated macrophages in nonspecific resistance to neoplasia.
Hibbs JB
J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
[No Abstract] [Full Text] [Related]
22. Immunotherapy of cancer. Present status and future potential.
Morton DL
Cancer; 1972 Dec; 30(6):1647-55. PubMed ID: 4565820
[No Abstract] [Full Text] [Related]
23. [Principal immunologic factors in carcinogenesis].
Melki G
Cah Med; 1973 Oct; 14(10):821-37. PubMed ID: 4806157
[No Abstract] [Full Text] [Related]
24. Adoptive transfer and specific active immunization of patients with malignant melanoma.
Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
[No Abstract] [Full Text] [Related]
25. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
26. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
David JR; David RR
Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
[No Abstract] [Full Text] [Related]
27. Spontaneous tumor regression. Experimental aspects.
McLaughlin AP; Gittes RF
Urology; 1974 May; 3(5):544-51. PubMed ID: 4133855
[No Abstract] [Full Text] [Related]
28. [Immunobiology of cancer].
Oettgen HF
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973; 205(1):21-36. PubMed ID: 4349192
[No Abstract] [Full Text] [Related]
29. Neuraminidase-induced enhancement of tumor growth in mice.
Froese G; Berczi I; Sehon AH
J Natl Cancer Inst; 1974 Jun; 52(6):1905-8. PubMed ID: 4834417
[No Abstract] [Full Text] [Related]
30. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
Shimoyama M
Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
[No Abstract] [Full Text] [Related]
31. Tumor-specific immunity and the Otolaryngologist.
Neel HB; Ritts RE
Ann Otol Rhinol Laryngol; 1973; 82(3):323-9. PubMed ID: 4576262
[No Abstract] [Full Text] [Related]
32. Progress of immunotherapy in the treatment of malignant melanoma.
Ariyan S
Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459
[No Abstract] [Full Text] [Related]
33. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
Jose DG; Seshadri R
Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
[No Abstract] [Full Text] [Related]
34. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
35. Immunological aspects of malignant melanoma of the choroid.
Rahi AH
Trans Ophthalmol Soc U K (1962); 1973; 93(0):79-91. PubMed ID: 4602170
[No Abstract] [Full Text] [Related]
36. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
37. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
38. Tumor-specific cellular immunity.
Cohen AM; Burdick JF; Ketcham AS
J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
[No Abstract] [Full Text] [Related]
39. [Transfer of the cytotoxic activity of lymphocytes immune to M. tuberculosis].
Averbakh MM; Kliuev VA; Litvinov VI
Biull Eksp Biol Med; 1973 Jun; 75(6):76-9. PubMed ID: 4204961
[No Abstract] [Full Text] [Related]
40. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
